This report is being submitted retrospectively as part of an internal review.A review of the device's manufacturing records revealed that the sensor lot met all requirements including sterilization requirements for release.The sensor is inserted by making a small incision and placing it under skin and potential for developing skin irritation/swelling/pain/ inflammation/infection around the insertion site is a known anticipated adverse event.In this particular case, the infection was noticed during removal procedure as the site was reddened and swollen.The hcp prescribed gentalin beta and connective tissue gauzes to treat the infected are.No further investigation was necessary for this complaint.To continue using eversense cgm system, a new sensor was inserted in another arm.
|
On november 25, 2022, senseonics was made aware of an incident where patient had an infection at insertion site (noticed during removal procedure).The site was red and swollen.Per the case information that was received, infection was related to removal procedure.The hcp prescribed gentalin beta and connective tissue gauzes.
|